Oncogenic miR-9 is a target of erlotinib in NSCLCs

EGFR-targeted cancer therapy is a breakthrough in non-small cell carcinoma. miRNAs have been proved to play important roles in cancer. Currently, for the role of miRNAs in EGFR-targeted cancer therapy is unclear. In this study, first we found that erlotinib reduced the expression of miR-9. MiR-9 exp...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Sci Rep
Asıl Yazarlar: Chen, Xi, Zhu, Lingjun, Ma, Zhuo, Sun, Geng, Luo, Xuan, Li, Min, Zhai, Sulan, Li, Ping, Wang, Xuerong
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Nature Publishing Group 2015
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4655475/
https://ncbi.nlm.nih.gov/pubmed/26593208
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/srep17031
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller